REQUEST A DEMO
Total
USD $0.00
Search more companies

Quanta Matrix Incorporated (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Quanta Matrix Incorporated Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korean-based company engaged in the development and production of in vitro diagnostics (IVD) medical devices. The Company s main products include a multi-diagnostic unique test platform, micro disc, antimicrobial susceptibility testing sepsis diagnostic equipment, molecular immunity diagnosis automation platform, rapid antituberculosis susceptibility testing equipment, rapid antituberculosis susceptibility testing kits, and others. In addition, the Company sells covid kits and engages in research and development of microbial diagnostic products. The Company was established on November 29, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 9, 2020.

Headquarters
16F, Bldg.B, Byc Highcity, 131, Gasan Digital 1-Ro, Geumcheo
Seoul; Seoul;

Contact Details: Purchase the Quanta Matrix Incorporated report to view the information.

Website: http://www.quantamatrix.com

Basic Information
Total Employees:
Purchase the Quanta Matrix Incorporated report to view the information.
Outstanding Shares:
Purchase the Quanta Matrix Incorporated report to view the information.
Registered Capital:
Purchase the Quanta Matrix Incorporated report to view the information.
Financial Auditors:
Purchase the Quanta Matrix Incorporated report to view the information.
Incorporation Date:
November 29, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Sas Uniq Quantamatrix Europe
Company Performance
Financial values in the chart are available after Quanta Matrix Incorporated report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
142.47%
Total operating revenue
130.72%
Operating profit (EBIT)
-12.34%
EBITDA
-14.09%
Net Profit (Loss) for the Period
-12.05%
Total assets
-50.29%
Total equity
-54.56%
Operating Profit Margin (ROS)
834.5%
Net Profit Margin
804.62%
Return on Equity (ROE)
-70.72%
Debt to Equity Ratio
1.28%
Quick Ratio
-4.09%
Cash Ratio
1.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?